共 50 条
- [31] NOVEL PREDICTORS OF BENIGN PATHOLOGY IN STAGE IA OR IB PATIENTS WITH NON-SEMINOMATOUS TESTICULAR GERM CELL MALIGNANCY UNDERGOING PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION JOURNAL OF UROLOGY, 2012, 187 (04): : E374 - E374
- [33] UTILIZATION AND IMPACT OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION IN ADVANCED NON-SEMINOMATOUS GERM CELL TUMOR JOURNAL OF UROLOGY, 2018, 199 (04): : E491 - E492
- [35] NUMBER OF LYMPH NODES RESECTED AT PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION AND CANCER-SPECIFIC SURVIVAL FOR NON-SEMINOMATOUS GERM CELL TUMOR OF THE TESTICLE JOURNAL OF UROLOGY, 2009, 181 (04): : 326 - 326
- [36] Improved clinical outcome for men with fibrosis at post-chemotherapy retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumors JOURNAL OF UROLOGY, 2007, 177 (04): : 330 - 330
- [38] DECLINING RATES OF RETROPERITONEAL LYMPH NODE DISSECTION FOR STAGE I NON-SEMINOMATOUS GERM CELL TUMORS: RESULTS FROM THE NATIONAL CANCER DATABASE JOURNAL OF UROLOGY, 2015, 193 (04): : E983 - E983